期刊： INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023; 61 (3)
Introduction: Tebipenem is a potential option for the treatment of a range of infections because of its oral dosing coupled with the safety profile of......
期刊： INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023; 61 (4)
ICEGpa1804 was identified in the genome of a serovar 2, ST279 isolate EHP1804 carrying eight different resistance genes from 200 Glaesserella parasuis......
期刊： INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023; 61 (6)
Bloodstream infections (BSI) caused by Gram-negative bacteria (GNB) in patients with hematological malignancies (HM) have been associated with high mo......
期刊： INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023; 62 (6)
Objectives: Vancomycin is used to treat Gram-positive infections in critically ill adults. For vancomycin administered by continuous infusion (CI), va......
期刊： INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023; 61 (6)
Methicillin-resistant Staphylococcus epidermidis (MRSE) endocarditis failing conventional therapy has been successfully treated with nafcillin plus da......
期刊： INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023; 62 (1)
Objectives: A previous study showed higher prevalence of Escherichia coli ( E. coli) expressing extended -spectrum beta-lactamases (ESBL-Ec) among men......
期刊： INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023; 62 (2)
Objectives: To compare the effectiveness of ceftazidime/avibactam (CAZ/AVI) and polymyxin B against carbapenem-resistant Gram-negative bacteria (CRGNB......
期刊： INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023; 62 (2)
Carbapenem-resistant Acinetobacter baumannii (CRAB) has been classified by the World Health Organization as being in the critical category of pathogen......
期刊： INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023; 62 (2)
Objectives: Few data on management of two-drug regimen (2DR) failure in people living with HIV (PLWH) are available. Methods: Retrospective study of t......
期刊： INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023; 62 (3)
Small RNAs (sRNAs) are post-transcriptional regulators of many biological processes in bacteria, includ-ing biofilm formation and antibiotic resistanc......
期刊： INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023; 62 (3)
Objectives: Antimicrobial resistance is a major global threat. Because of the stagnant antibiotic pipeline, synergistic antibiotic combination therapy......
期刊： INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023; 62 (5)
Background: Combination therapy can enhance the activity of available antibiotics against multidrug-resistant Gram-negative bacteria. This study asses......
